Related Experiment Video
Updated: May 3, 2026
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
[Molecular markers of gastrointestinal tumors and individualized treatment]
1Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China. cshou@vip.sina.com.
Abstract:
Gastrointestinal cancer is one of the most common malignant tumors in China which affects people health seriously. Along with the investigation of the cancer molecular markers and the application of novel target agents, the therapeutic modalities for gastrointestinal cancers have been changing gradually. More and more target drugs, such as trastuzumab, cetuximab, bevacizumab,have been used in clinical practice. The individualized therapy based on the molecular classification will benefit more patients and is the inevitable trend of gastrointestinal cancer treatments in the future.
Insights
Gastrointestinal cancer treatments are evolving with targeted therapies. Personalized medicine based on molecular classification offers a promising future for improving patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Gastrointestinal cancer is a significant health concern in China.
- Traditional treatments are being enhanced by novel targeted agents.
- Molecular markers are crucial for understanding cancer progression.
Discussion:
- Targeted drugs like trastuzumab, cetuximab, and bevacizumab are increasingly used.
- These therapies represent a shift towards precision medicine.
- Individualized treatment strategies are becoming more prevalent.
Key Insights:
- Molecular classification enables personalized gastrointestinal cancer therapy.
- Targeted agents offer new hope for patients.
- The integration of molecular data improves treatment efficacy.
Outlook:
- Individualized therapy is the future trend for gastrointestinal cancer.
- Further research into molecular markers will refine treatment protocols.
- Advancements in targeted therapies promise better patient survival rates.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...